Alnylam Pharmaceuticals, Inc.
ALNY
$332.92
$1.680.51%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
2/28/2026
-
MarketBeat
2/28/2026
-
MarketBeat
2/28/2026
-
Insider Monkey
2/27/2026
-
Simply Wall St
2/26/2026
-
MarketBeat
2/26/2026
-
Simply Wall St
2/24/2026
-
Simply Wall St
2/23/2026
-
Benzinga
2/23/2026
-
Business Wire
2/21/2026
-
MarketBeat
2/21/2026
-
MarketBeat
2/21/2026
-
MarketBeat
2/20/2026
-
The Online Investor
2/20/2026
-
MarketBeat
2/20/2026
-
Insider Monkey
2/19/2026
-
Simply Wall St
2/19/2026
-
Insider Monkey
2/19/2026
-
MarketBeat
2/19/2026
-
MarketBeat
2/19/2026
-
Globe Newswire
2/19/2026
-
MarketBeat
2/18/2026
-
MarketBeat
2/18/2026
-
Ticker Report
2/18/2026
-
MarketBeat
2/18/2026
-
Insider Monkey
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 12, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 551 8200
Address
675 West Kendall Street
Cambridge, MA 02142
Cambridge, MA 02142
Country
Year Founded
Business Description
Sector
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally. The...
more